Related Experiment Video

Updated: Mar 9, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.5K

Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications

Brittany R Silverman1, Jiaqi Shi2

  • 1Department of Pathology, School of Medicine, University of Michigan, Ann Arbor, MI 48109, USA. bsilv@umich.edu.

International Journal of Molecular Sciences
|December 22, 2016
PubMed

Insights

Pancreatic cancer involves epigenetic alterations, impacting gene expression and tumor development. Understanding these changes offers potential for new diagnostic biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Pancreatic cancer has a poor prognosis, with a five-year survival rate below 7%.
  • Genetic alterations targeting epigenetic regulators are increasingly recognized in pancreatic cancer development.
  • Epigenetic mechanisms like DNA methylation and histone modifications play crucial roles in gene regulation.

Purpose of the Study:

  • To review current knowledge on epigenetic alterations in pancreatic cancer.
  • To discuss the role of epigenetic reprogramming in pancreatic cancer progression.
  • To explore clinical applications of epigenetic regulators as diagnostic biomarkers and therapeutic targets.

Main Methods:

  • Literature review of current research on pancreatic cancer epigenetics.
  • Analysis of studies detailing DNA methylation, histone modifications, chromatin remodeling, and non-coding RNAs.
  • Discussion of how these epigenetic modifications influence gene expression and tumor development.

Main Results:

  • Epigenetic alterations are significant drivers in pancreatic cancer.
  • These modifications affect chromatin structure and gene expression, contributing to aberrant cellular activity.
  • The precise impact on epigenetic reprogramming across different cancer stages requires further elucidation.

Conclusions:

  • Epigenetic regulators are critical in pancreatic cancer development and progression.
  • Targeting epigenetic alterations presents promising avenues for novel diagnostic and therapeutic strategies.
  • Further research is needed to fully understand the complex epigenetic landscape in pancreatic cancer.
Keywords:
clinical implicationepigenetic regulatorsgenetic alterationspancreatic cancerpancreatic neoplasms

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

966
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

4.1K

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
824